Transparent corporate social responsibility ratings to help you change the world.
Search a Company's Sustainability
User login form 2012
SUBSCRIBE NOW, for all the benefits.
sustainability in 12 sub-categories.
ROLLBACK and view CSR ratings
over time (pro level).
EXPORT customized search results
VIEW companies' CSR sites and
underlying data from many sources.
ANNUAL PLAN, 25% OFF
BioMarin Pharmaceutical Inc.
BioMarin is a multinational biopharmaceutical company that specializes in providing first-to-market therapeutics to patients with rare genetic diseases. The company's product portfolio comprises three approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. The company was established in 1997 and employs a staff of 675 worldwide.
Basic corporate social responsibility ratings
Data sources for this company
(unregistered users only see a sample of this list of sources)
Subcategory CSR ratings
Special issues that affect this company
Original data values
(registered users can see the list, subscribers can see the data details for most sources)
Please register to see a list of flags for this company